Trials / Conditions / Gastro-entero-pancreatic Neuroendocrine Tumors
Gastro-entero-pancreatic Neuroendocrine Tumors
3 registered clinical trials studyying Gastro-entero-pancreatic Neuroendocrine Tumors — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Protocol ITANET - Registry NCT04282083 | Italian Association Neuroendocrine Tumors | — |
| Terminated | 177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positiv NCT02736448 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Phase 2 |
| Completed | Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients NCT02736500 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Phase 1 / Phase 2 |